| Literature DB >> 3877899 |
Abstract
Diprivan is a new anesthetic agent that is being tested in the United States after preliminary trials in Europe. Characteristic features include rapid induction and recovery, with cardiovascular and respiratory changes that are insignificant at the recommended dose. Lack of excitatory and emetic complications, along with absence of any toxic effects to date, have contributed to its consideration as an auspicious new agent.Entities:
Mesh:
Substances:
Year: 1985 PMID: 3877899 DOI: 10.1016/0030-4220(85)90356-1
Source DB: PubMed Journal: Oral Surg Oral Med Oral Pathol ISSN: 0030-4220